A Trial of Oral BEZ235 and BKM120 in Combination With Paclitaxel With or Without Trastuzumab
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic or Locally Advanced Solid Tumors
Interventions: DRUG: BEZ235 + paclitaxel|DRUG: BKM120 + paclitaxel|DRUG: BEZ235 + paclitaxel + trastuzumab|DRUG: BKM120 + paclitaxel + trastuzumab
Sponsor: Novartis Pharmaceuticals